Thursday 25 February 2021

Negative Pressure Wound Therapy Market Profile, Sales, Cost and Capacity By 2023

 Negative Pressure Wound Therapy Market Research Report 2020, Size, Share, Growth, Trends and Industry Analysis By Product Type (Conventional Negative Pressure Wound Therapy Devices and Others), Wound Type (Surgical and Traumatic Wounds, Ulcers, and Burns), & End-User (Hospitals and Others)- Global Forecast till 2023

Negative Pressure Wound Therapy Market Overview

Global negative pressure wound therapy (NPWT) market is required to become essentially over the conjecture time frame. It is foreseen that the market held a market estimation of USD 2.24 billion out of 2017 and is anticipated to enlist a CAGR of 6.7% over the conjecture time frame. The negative-pressure wound therapy (NPWT) is a fixed wound-care framework and is significantly shown for huge incessant industrious wounds and intense entangled wounds. The framework comprises of an electronically controlled siphon and a froth dressing that depletes the wound. In this therapy, negative pressure is applied over the wounds for advancing mending. NPWT devices are for the most part used to deal with a few sorts of intense and constant wounds, for example, diabetic ulcers, venous ulcers, blood vessel ulcers, pressure ulcers, and first-and severe singeing.

Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6514

Factors including the developing predominance of interminable diseases, such as diabetes and stoutness, expanding causalities brought about by injury and mishaps, and developing spending on ceaseless and careful wounds are relied upon to impel the development of the market. As indicated by the Centers for Disease Control and Prevention (CDC), in 2015, about 2.8 million individuals were hospitalized because of wounds. In addition, the expanding pace of cesarean areas in old moms is required to build the post-employable utilization of NPWT devices.

Moreover, the rising utilization of streamlined single-use gadgets is foreseen to add to market development. Nonetheless, the significant expense of this therapy over the traditional wound therapy and a lack of prepared social insurance experts can hamper the market development over the gauge time frame.

Negative Pressure Wound Therapy Market Competitive Analysis:

Some of the major companies in the global negative pressure wound therapy (NPWT) market include Cardinal Health, ACELITY L. P. Inc., ConvaTec Group Plc., Smith & Nephew, DeRoyal Industries, Inc., Lohmann & Rauscher International GmbH & Co. Kg, Medela, Talley Group, Genadyne, and Mölnlycke Health Care AB (A Subsidiary of Investor AB).

Negative Pressure Wound Therapy Market Segmentation:

The negative pressure wound therapy (NPWT) market is segmented on wound type, product type, end-user, and region.

The market, on the basis of product type, has been segmented into conventional negative pressure wound therapy devices, accessories, and single-use negative pressure wound therapy devices. Of these, the conventional segment held largest share of the global market for negative pressure wound therapy (NPWT) in 2017. This growth of the segment is attributable to the ability of conventional negative pressure wound therapy devices to manage severe wound exudates.

The market, by wound type, is segmented into ulcers, surgical and traumatic wounds, and burns. Of these, the ulcers segment is further segmented into venous ulcers, diabetic foot ulcers, pressure ulcers, and others.

The market, by end-user, is segmented into home care settings, hospitals, and others.

Negative Pressure Wound Therapy Market Regional Analysis:

Regionally, the negative pressure wound therapy (NPWT) market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, North America is estimated to remain dominant in the global negative pressure wound therapy (NPWT) market in the coming period owing to the well-developed human services part, developing events of constant wounds, rising commonness of diabetes, and rising geriatric populace.

The negative pressure wound therapy market in the Asia-Pacific area comprises of nations, specifically, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific district is relied upon to be quickest developing locale attributable to the tremendous patient populace of constant sicknesses, for example, diabetes in nations, for example, India and China, high paces of consumes and damage cases, and expanding improvement in the social insurance division in most of nations in the Asia-Pacific area. As per the World Health Organization, more than 1 000 individuals are decently or seriously consumed each year in India.

Europe is required to hold the second biggest situation in the global negative pressure wound therapy market. The market development in this district is credited to the expanding number of mishaps and the developing predominance of diabetes combined with created social insurance foundation.

Table Of Contents:

Chapter 1. Report Prologue


Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations


Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation


Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment


Chapter 5. Market Factor Analysis

…Continued

Get More Information on Negative Pressure Wound Therapy Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-6514

Brows More Healthcare Related Research Reports:

Keloid Treatment Market | Therapeutics, Size, Growth and Forecast To 2023

Controlled Release Drug Delivery Market Share, Trends, Size and Industry Forecast to 2023

Cold Pain Therapy Market Research Report – Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Malaria Diagnostics Market Landscape, Key Companies Profile and Solutions | Forecast to 2023

 Malaria is a serious life-threatening disease caused by a parasite, transmitted by the bite of infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium parasite. When the infected mosquito bites you, the parasite is released into your bloodstream. Once the human body becomes the host for the parasite it travels to the liver and matures. After some days, the mature parasite enters the bloodstream and starts to infect red blood cells (RBC). Humans suffering from malaria frequently experience fever, headache, weakness, vomiting

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6432

The global malaria diagnostics market is expected to register a significant growth of 4.6 % CAGR during the forecast period (2018–2023)

The improvements in technological advancements related to diagnostic tools with the growing demand for treatment in malaria-endemic countries is driving this market. Major factors driving the growth of the market are raising funds from the government, an increase in association between the industry and research centers. In the current years, there has been a renewed interest and commitment by the World Health Organization (WHO) to eradicate malaria in around 35 countries by 2030. World Health Organization (WHO) also estimated that by 2016, there would be 216 million clinical episodes and 445,000 deaths only due to malaria. The malaria diagnostic tests play a major role in recognizing the malarial cases and thus boosting the growth of malaria diagnosis market.

However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market. The weak regulatory framework and lack of awareness across the emerging nations is a prime concern for the manufacturers and healthcare providers. The absence of strong import export guidelines can lead to the use of substandard products that can lead to additional complications for patients. Besides, the long registration procedures, the market entry parameters must be assessed carefully for investment considerations.

Key Players

Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.

Segmentation

The global malaria diagnostics market has been segmented on the basis of technology and end-user.

On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).

On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European malaria diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

In the malaria diagnostics market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.

The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.

The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/malaria-diagnostics-market-6432

Brows More Healthcare Related Research Reports:

Smart Pills Market Growth Opportunity By Application, Size and Trends

Electric Wheelchair Market Growth Analysis, Size, Global Share and Industry Forecast to 2023

Bioprocess Containers Market | Technology, Trends and Growth Forecast To 2023

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Absorbable Surgical Sutures Market Segmentation, Dynamics Till 2023

 Global Absorbable Surgical Sutures Market: By Type Synthetic Suture, Structure Monofilament Suture and Multifilament Suture), Technique Continuous, Interrupted Sutures, Application General Surgeries), End-Users Clinics – Global Forecast Till 2023  

Segmentation Analysis:

The global absorbable surgical sutures market has been segmented on the basis of type, structure, application, and end-user. On the basis of type, the market has been classified as synthetic and natural sutures.

Synthetic sutures have been segmented into poliglecaprone suture (Monocryl), Vicryl, and polydioxanone suture (PDS). Natural sutures have been segmented into collagen, catgut suture, and polyglycolic acid suture.

Get Prim Sample Report at https://www.marketresearchfuture.com/sample_request/6363

On the basis of structure, the market has been classified as monofilament and multifilament sutures. On the basis of application, the market has been classified as general surgeries, cardiovascular surgeries, gynecological surgeries, orthopedic surgeries, and other surgeries. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.

Competitive Players:

Some of the key players in the global absorbable surgical sutures market are Ethicon Inc. (US), B. Braun Melsungen AG (Germany), DemeTECH Corporation (US), Medtronic plc (Ireland), Internacional Farmaceutica, S.A. de C.V. (Mexico), Sutures India Pvt. Ltd. (India), Péters Surgical (France), Smith & Nephew plc (UK), EndoEvolution, LLC (US), Boston Scientific Corporation (US), Johnson & Johnson Private Limited, Conmed Corporation(US), W.L. Gore & Associates(US), 3M Healthcare (US).

Absorbable Surgical Sutures Market – Scenario

Surgical Sutures, commonly known as stitches, are sterile, surgical threads which are used to repair cuts and wounds. A suture is a medical device that doctors and surgeons, use to hold skin, blood vessels, and all other tissues of the human body together, after any surgery. The tissues are held together until the healing completes. Absorbable sutures are broadly used in multiple surgeries, specifically in surgeries performed on internal organs, as they are biodegradable and get hydrolyzed in the body tissue after a certain period.  The global market for absorbable surgical sutures is expected to grow with a steady rise and is expected to continue doing so over the next few years.

A substantial growth in the frequency of health conditions related to skin, soft tissues, and peripheral vascular surgery is the key factor that boosts the growth of this market. The increase in aged population and the rising frequency of musculoskeletal diseases are also anticipated to drive the global market over the forecast period. Factors such as less rate of wound infection have made absorbable sutures extremely common among consumers, which is reflecting greatly on their demand.  However, the increasing demand for advanced wound closure materials and lack of product innovations in surgical sutures act as major barriers for this market.

North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, increasing number of surgical procedures, growth in chronic diseases, and easy adoption due to the FDA and CE marking approval of the market.  Factors such as increasing lifestyle changes, increasing frequency of obesity cases, and increasing elderly population in North America help to boost the market growth.

Regional Analysis                                                                     

In the absorbable surgical sutures market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to rising frequency of cardiovascular disorders, increasing number of surgeries, and increasing demand for advanced treatment procedures.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.

The market in the Middle East and Africa is expected to account for the smallest share of the global absorbable surgical sutures market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Browse Complete 100 Pages Premium Research Report Enabled With 88 Respective Tables And Figures At: https://www.marketresearchfuture.com/reports/absorbable-surgical-sutures-market-6363

Chapter 1. Report Prologue 

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED………!

LIST OF TABLES

Table 1 Global Absorbable Surgical Sutures Synopsis, 2018–2023

Table 2 Global Absorbable Surgical Sutures Estimates And Forecast, 2018–2023 (USD Million)

Table 3 Global Absorbable Surgical Sutures, By Region, 2018–2023 (USD Million)

Table 4 Global Absorbable Surgical Sutures, By Type, 2018–2023 (USD Million)

Table 5 Global Absorbable Surgical Sutures, By Structure, 2018–2023 (USD Million)

Continued….!

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Absorbable Surgical Sutures

Figure 3 Segmentation Market Dynamics For Global Absorbable Surgical Sutures

Figure 4 Global Absorbable Surgical Sutures Share, By Type, 2017

Figure 5 Global Absorbable Surgical Sutures Share, By Structure, 2017

Figure 6 Global Absorbable Surgical Sutures Share, By Application, 2017

Figure 7 Global Absorbable Surgical Sutures, By End-Users, 2018–2023 (USD Million)

Figure 8 Global Absorbable Surgical Sutures Share, By Region, 2017

Brows More Healthcare Related Research Reports:

Absorbable Surgical Sutures Market Outlook | Demand Overview, Share Analysis and Industry Forecast to 2023

Malaria Diagnostics Market Share, Techniques, Trends, Growth Analysis, Industry Forecast to 2023

Negative Pressure Wound Therapy Market Share, Industry Trends and Forecast to 2023

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services

Palliative Care Market Overview, Growth, Future Outlook To 2023

 Market Scenario:

Palliative care helps to improve the quality of life of patients and their families facing the problems of serious illness. The main focus of Palliative care is to provide relief from symptoms and stress of a serious illness. Their main goal is to improve the quality of life for both the patient and the family. Palliative care treats people living with a serious illness such as cancer, cardiac diseases such as congestive heath failure, kidney failure, Alzheimer’s and many more. It improves the quality of life of the patient and supports the primary physician, patient, and family. In last 15 years, the Palliative care market has a stunning growth and the factors that have led to the growth of this market are growing the aging population, increase in chronic life-threatening disease, initiative taken by the government and non- profit organization, and rise in government funding.

However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6336

Segmentation

The Global Palliative Care Market is segmented into types such as private residence care, hospice inpatient care, hospital inpatient care, nursing home and residential facility care and others. On the basis of application, the market is further segmented into cancer, cardiac diseases such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), kidney failure, Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and many more. On basis of end-user, the market is further segmented into hospitals, home care settings, palliative care centers, long-term care centers & rehabilitation centers.

Key Players

  • Vitas Healthcare Corporation
  • Skilled Healthcare Group Incorporated
  • Sunrise Senior Living LLC
  • Kindred Healthcare Incorporated
  • Gentiva Health Services Incorporated
  • Home Instead Senior Care Incorporated
  • Amedisys Incorporated
  • Genesis HealthCare Corporation

Regional Market Summary

The market has been segmented, by region, into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Global Palliative Care Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Global Palliative Care Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Global Palliative Care Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Palliative care market in the Middle East and Africa has been segmented into the Middle East and Africa.

In terms of market value, North America will dominate the Palliative care market during the forecast period. Increasing incidences of life-threatening illness such as cancer, cardiovascular diseases, Alzheimer’s disease, kidney failure, chronic obstructive pulmonary disease and many more are some of the factors which are responsible for the growth of the market during the forecast period. In 2015 on average 90 % of US hospitals containing 300 beds or more provide Palliative care services to their patients. This has led to the growth of the market in coming years. The European market is expected to be the second-largest Palliative care market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of Palliative care centers worldwide, extending application for homecare, increasing number of qualified physicians for Palliative care center and expanding aging demographics are some of the factors responsible for the rise in the global Palliative care market. Asia-Pacific is expected to be the fastest-growing Palliative care market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global Palliative care market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global Palliative care market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Browse Report at: https://www.marketresearchfuture.com/reports/palliative-care-market-6336 

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Brows More Healthcare Related Research Reports:

Nutraceutical Excipients Market Share, Applications, Industry Analysis and Forecast to 2023

Endometrial Cancer Market Application, Growth, Trends, Size | Global Industry Analysis 2023

Palliative Care Market Research Report –Global Forecast to 2023| MRFR

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Endometrial Cancer Market Demand, Services and Future Outlook By 2023

 Endometrial cancer, also known as uterine cancer, is defined as an abnormal growth of endometrium cells in the uterus. Market Research Future (MRFR) has published a research report about the global endometrial cancer market that estimates robust growth for this market between 2018 and 2023. The key factors driving this market are changes in sedentary lifestyle, growing consumption of unhealthy diet, growing obesity among women, increase in menopausal hormone therapy, increasing occurrence of Polycystic Ovarian Syndrome (PCOS), increasing prevalence of breast or ovarian tumor, rising prevalence of endometrial cancer, and various socioeconomic factors.

FREE SAMPLE COPY OF Endometrial Cancer Market Report @ https://www.marketresearchfuture.com/sample_request/6226

The global endometrial cancer market has been segmented on the basis of diagnosis, end users, treatment, and lastly region. On the basis of diagnosis, this market has been segmented on the basis of dilation & curettage (D&C), diagnostic laparoscopy, endometrial biopsy, pelvic examination, and transvaginal ultrasound. Based on end users, the market has been segmented into ambulatory surgical centers, diagnostic centers, feminist health centers, gynecology centers, and hospitals & clinics.

The treatment-based segmentation of this market covers chemotherapy, hormone therapy, hysterectomy techniques, radiation, and palliative care. Chemotherapy has been further segmented into carboplatin, cisplatin, doxorubicin, and paclitaxel. Hormone therapy has been segmented into aromatase inhibitors, luteinizing hormone-releasing hormone agonists, progestins, and tamoxifen. The further segmentation of hysterectomy techniques comprises of open abdominal hysterectomy, robotic hysterectomy, total laparoscopic hysterectomy, and total vaginal hysterectomy. The radiation has been sub-segmented into external radiation and internal radiation (brachytherapy).

The regional segmentation of the global endometrial cancer market has been segmented into The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas currently hold the largest market share, and during the forecast period, they are expected to retain their spot. This region is experiencing a growing number of endometrial patients who are spending much on diagnostic and treatment. Due to a well-structured healthcare system and extensive research units, the market is strong in this region. In the Americas, North America is a bigger market than South America because, in North America, more advanced medical facilities and population with higher per capita income are available. The biggest country based markets in this region are the United States of America (USA) and Canada.

Currently, Europe is the second largest market. Robust healthcare sector and advanced technologies are the driving factors for the European market. Due to reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. Some key players in this market-based in Europe are based in strong economies like the United Kingdom (UK), Germany, Netherlands, and France. During the forecast period, the Asia Pacific can also witness significant growth in the market. In this region, the market is driven by rising incidence of cervical cancer in countries such as India and China. MEA market is small due to lack of awareness, lack of education, lack of technological development, political instability, poor healthcare, and healthcare not considered a priority by most governments.

Endometrial Cancer Market Analyzed Top Key Players

The key players in the global endometrial cancer market include Bayer AG (Germany), Boston Scientific Corporation (USA), Celgene Corporation (USA), Conceptus Inc. (USA), CooperSurgical Inc. (USA), General Electric Company (USA), Hologic Inc. (USA), Johnson & Johnson (USA), Karl Storz GmbH & Co. Kg (Germany), Koninklijke Philips N.V. (the Netherlands), Pfizer Inc. (USA), LiNA Medical USA (USA), and LUPIN (India).

Browse Complete Report @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226

Latest Industrial News

  • Leaders from UT Health San Antonio and MD Anderson Cancer Center have discussed the partnership between the institutions for cancer research and treatment and its benefit to local cancer patients. 5 SEP 2018
  • The FDA has granted a breakthrough therapy designation to the combination of lenvatinib (Lenvima) and pembrolizumab (Keytruda). This therapy is useful for the treatment of patients with advanced and/or metastatic non–microsatellite instability-high (MSI-H)/proficient mismatch repair endometrial carcinoma. However, only those who have progressed after more than 1 prior systemic therapy are eligible for this treatment. 1 AUG 2018

Brows More Healthcare Related Research Reports:

Injection Pen Market Size, Share, Industry Analysis and Forecast to 2023

Biomarker Technologies Market – Global Industry Size, Trends, Share and Forecast by 2023

Kidney Function Test Market | Type, Technology and Growth Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services

Nutraceutical Excipients Market Key Companies Profile, Research and Insights | Forecast to 2023

 MarketResearchFuture.com (MRFR) in its recently Announced study report asserts that the “Global Nutraceutical Excipients Market” growing further will reach USD 4800 Mn. by 2023 with Top Companies and Mega Trends.

Nutraceutical Excipients Market – Summary

The Global Nutraceutical Excipients Market is anticipated to grow from USD 3.1 Bn in 2017 to USD 4.81 Bn by the end of 2023. The steadily growing demand for nutraceutical products is expected to play an important role in driving the nutraceutical excipients market in the forthcoming years.  Consumers are increasingly demanding nutraceutical products, which is supporting the growth of nutraceutical excipients sales. Excipients typically assist in the stabilization and protection of the final product from adverse and undesirable chemical reactions, making them an important preventive care product.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/6097

Nutraceutical Excipients Market – Scenario

The global demand for nutraceutical excipient continues to move upward. Tailwinds are helping the nutraceutical industry to flourish expediently. In recent years, sales of nutraceutical products have increased to significant extents, partly owing to the increased healthcare spending in various parts of the world.

Evolving eating habits and growing health consciousness among consumers is reflecting favorably on the global market for nutraceutical excipients. The market is expected to surpass a valuation of USD 4800 Mn by 2023-end. At the same time, the expansion of the wellness industry is opening new windows of growth for nutraceutical items. The aforementioned factors and trends are expected to govern the global nutraceutical excipient market during the forecast period.

Report Coverage:

Market value, market share, player analysis, value chain analysis, Porter’s five forces model, demand & supply: gap analysis, investment opportunities analysis, pricing analysis, technological trends, country level break down for function, type, form, and application.

Players Covered:

Cargill Corporation, Ingredion, Associated British Foods plc, Kerry, Roquette Freres SA, JRS PHARMA, Innophos, Inc., DowDupont, Sensient Technology Corporation, and Hilmar Ingredients.

Nutraceutical Excipients Market – Regional Analysis:

Globally, the North America market dominates the nutraceutical excipients market. Increasing prevalence of respiratory diseases and chronic diseases drives the market growth in the region. The sedentary lifestyle is the primary factor fuelling the incidences of chronic diseases.

Also, other factors like the rising geriatric population, increasing healthcare expenditure, coupled with the growing awareness among people towards the benefits of healthy diet, are increasing sales of nutraceutical and hence the market growth of nutraceutical excipients in the region.

The Europe market accounts for the second-largest market for the Nutraceutical excipients owing to the presence of well-established players and growing healthcare expenditures in the region. Certainly, the resurging economy is the main driving force increasing the market value in the region.

Nutraceutical Excipients Market – Segmentation

The global nutraceutical excipients market has been segmented based on function, form, application, type, and region. By function, the market has been segmented into fillers, diluents & bulking agents, binders, disintegrants, coating agents, lubricants, sweeteners, and colors & flavors. The fillers, diluents & bulking agents segment is projected to expand at a CAGR of 8.34% during the forecast period. The binders segment holds the second spot and is also likely to witness a strong growth over 2023. By form, the market has been segmented into liquid and dry, with the former currently accounting for nearly 55% share of the market and reaching a valuation of more than USD 1 Bn in 2017.

The dry segment is anticipated to witness a CAGR of 7.34% during the review period. By application, the market has been segmented into probiotics & prebiotics, proteins & amino acids, omega-3 fatty acids, and vitamins & minerals. In 2017, the probiotics & prebiotics segment commanded 47.5% market share and is expected to expand at an above-average CAGR. However, the vitamins & minerals segment is set to grow at the highest CAGR of 7.92% over the course of the assessment period. By type, the market has been segmented into artificial and natural/organic. The artificial segment will continue to outperform the natural/organic segment in 2018 and beyond. However, the increased level of awareness among consumers about the benefits of natural/organic nutraceuticals products is expected to provide an impetus to the natural/organic segment.

Browse Report at: https://www.marketresearchfuture.com/reports/nutraceutical-excipients-market-6097 

Major TOC of Nutraceutical Excipients Market Research Report – Forecast to 2023:

1 Report Prologue

2 Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Nutraceutical Excipients Market, By Function

7 Global Nutraceutical Excipients Market, By Form

8 Global Nutraceutical Excipients Market, By Application

9 Global Nutraceutical Excipients Market, By Type

10 Global Nutraceutical Excipients Market, By Region

11 Competitive Landscape

12 Company Profiles

13 Conclusion

14 Appendix

Brows More Healthcare Related Research Reports:

Dietary Supplements in the Age of Personalized Nutrition Market Trends, Size, Share, Global Industry Forecast to 2023

Pediatric Craniosynostosis Treatment Market 2019 | Global Industry Analysis and Forecast till 2023

Myasthenia Gravis Disease Market | Therapeutics, Size, Growth and Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Kidney Function Test Market Sales, Cost, Profit To 2023

 The Global Kidney Function Test Market Is Expected to Reach an Approximate CAGR of 5.7% During the Forecast Period. Kidney Function Tests Are Carried Out to Evaluate the Functioning of Kidneys.

Market Synopsis

Kidney function tests are used to check the excretory function of the kidneys. These tests include blood tests, urine tests and, imaging tests. Kidney function tests are carried out when a patient suffers from  Acute Renal Failure (ARF), Chronic Kidney Disease (CKD), renal vein thrombosis, renal hypertension, renal infections, renal stones, renal masses, and renal transplant. Chronic kidney diseases are mainly caused due to diabetes, high blood pressure, certain drugs, and cancer.

The kidney function test market is dominated by the Americas due to the increasing prevalence of chronic kidney diseases. According to the National Kidney Foundation 2017, 1 in 3 American adults suffer from kidney disease.

Avail Free Sample@ https://www.marketresearchfuture.com/sample_request/6171

Furthermore, the rising prevalence of diabetes contributes to the growth of the market. According to the National Diabetes Statistics Report of the Centers for Disease Control and Prevention (2017), around 30.3 million people in the U.S. have diabetes. It also mentions that 87.5 % of the diabetic population is obese. Such high incidence rate of diabetic population in the U.S. drives the market growth in this region.

Key Players

Some of the key players for the global kidney function test market are

  • Urit Medical
  • Sysmex Corporation
  • Siemens Healthcare GmbH (Germany)
  • Hoffmann-La Roche Ltd
  • Randox Laboratories
  • Opti Medical
  • Nova Biomedical
  • Beckman Coulter
  • ARKRAY Inc.
  • Acon Laboratories
  • Abbott
  • 77 Elektronika
  • Medical Care (Germany)
  • Baxter (U.S.)
  • Boston Scientific (U.S.)
  • and others.

Other factors such as the increasing trend of cigarette smoking, alcohol consumption, growing geriatric population and rising obesity within this region drive the market growth in the U.S. According to the CDC 2016, 93.3 million people in the U.S. are obese. Such growing prevalence of obesity, diabetes and kidney diseases in the U.S. provides favorable backgrounds for the market to grow.

Segmentation

The global kidney function test market is segmented on the basis of tests, product, and end-user. The kidney function test market, by tests categorized into blood tests, imaging tests, urine tests balloons, and kidney biopsy. The blood tests category includes serum creatinine, Glomerular Filtration Rate (GFR), and Blood Urea Nitrogen (BUN). The imaging tests segment includes ultrasound and CT scan. The urine tests category includes urinalysis, urine protein, microalbuminuria, and creatinine clearance.  The product segment is segmented into dipsticks, disposables, and reagents. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, academic research laboratories, and others.

Regional Analysis

The Americas is expected to dominate the kidney function test market during the forecast period. The rise in the occurrence of chronic kidney diseases drives the market in this region. According to the Centers for Disease Control and Prevention (2017), 30 million Americans are affected by Chronic Kidney Disease. It is also mentioned that CKD is more prevalent in women than in men. This influences the market growth during the forecast period.

Europe (U.K., Belgium, France, and the Netherlands) is second in the market owing to the increasing prevalence of diabetes and growing healthcare expenditure. According to the World Health Organization 2015, 60 million people in Europe are affected by diabetes. High prevalence of diabetes drives the market growth in this region.

Asia Pacific is expected to observe growth in the global kidney function test market owing to increasing prevalence of diabetes, rising geriatric population, high blood pressure, and change to an unhealthy lifestyle. High blood pressure damages the blood vessels of the kidney which eventually leads to improper functioning of the kidney. According to the Blood Pressure Association in 2015, large patient pool with high blood pressure was found in South Asia with 226 million people in China and 199 million in India. This provides favorable backgrounds for the market growth.

According to the Centers for Disease Control and Prevention 2017, 44% of the diabetic patients suffered from End-Stage Renal Disease (ESRD) in the U.S. The prevalence of diabetes increases the potential patients for kidney function test, providing favorable backgrounds for the market to grow. Also, other factors such as growing geriatric population and technological advancements drive the growth of the market.

However, factors such as high cost of diagnostic procedures, infections, and huge initial investments are expected to restrict the market growth during the forecast period.

Browse Complete Premium Research Report along with Detailed TOC at https://www.marketresearchfuture.com/reports/kidney-function-test-market-6171

LIST OF TABLES

Table 1 Kidney Function Test Market Industry Synopsis, 2018–2023

Table 2 Global Kidney Function Test Market Estimates & Forecast, 2018–2023, (USD Million)

Table 3 Global Kidney Function Test Market, By Region, 2018–2023, (USD Million)

Table 4 Global Kidney Function Test Market, By Tests, 2018–2023, (USD Million)

Table 5 Global Kidney Function Test Market, By Product, 2018–2023, (USD Million)

Table 6 Global Kidney Function Test Market, By End-User, 2018–2023, (USD Million

Table 7 North America Kidney Function Test Market, By Tests, 2018–2023, (USD Million)

Table 8 North America Kidney Function Test Market, By Product, 2018–2023, (USD Million)

Table 9 North America Kidney Function Test Market, By End-User, 2018–2023, (USD Million)

Brows More Healthcare Related Research Reports:

Type 2 Diabetes Mellitus Treatment Market Research Report – Forecast to 2023 | MRFR

Hemophilia Treatment Market Overview, Size, Share, Growth and Industry Trends

Global Bariatric Surgery Market Size, Trends, Growth 2017-2023

About Market Research Future: Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...